DK0724600T3 - Fremgangsmåde til fremstilling af et koncentrat af inter-alfa-trypsininhibitor til terapeutisk anvendelse og det fremstillede koncentrat - Google Patents

Fremgangsmåde til fremstilling af et koncentrat af inter-alfa-trypsininhibitor til terapeutisk anvendelse og det fremstillede koncentrat

Info

Publication number
DK0724600T3
DK0724600T3 DK94931070T DK94931070T DK0724600T3 DK 0724600 T3 DK0724600 T3 DK 0724600T3 DK 94931070 T DK94931070 T DK 94931070T DK 94931070 T DK94931070 T DK 94931070T DK 0724600 T3 DK0724600 T3 DK 0724600T3
Authority
DK
Denmark
Prior art keywords
concentrate
pct
alpha
inter
therapeutic use
Prior art date
Application number
DK94931070T
Other languages
Danish (da)
English (en)
Inventor
Catherine Michalski
Jacques Mizon
Original Assignee
Aetsrn
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aetsrn filed Critical Aetsrn
Application granted granted Critical
Publication of DK0724600T3 publication Critical patent/DK0724600T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8114—Kunitz type inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK94931070T 1993-10-18 1994-10-17 Fremgangsmåde til fremstilling af et koncentrat af inter-alfa-trypsininhibitor til terapeutisk anvendelse og det fremstillede koncentrat DK0724600T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9312346A FR2711371B1 (fr) 1993-10-18 1993-10-18 Procédé de préparation d'un concentré d'inter-alpha-trypsine inhibiteur à usage thérapeutique et concentré obtenu.
PCT/FR1994/001197 WO1995011260A1 (fr) 1993-10-18 1994-10-17 Procede de preparation d'un concentre d'inter-alpha-trypsine inhibiteur a usage therapeutique et concentre obtenu

Publications (1)

Publication Number Publication Date
DK0724600T3 true DK0724600T3 (da) 2002-05-27

Family

ID=9451908

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94931070T DK0724600T3 (da) 1993-10-18 1994-10-17 Fremgangsmåde til fremstilling af et koncentrat af inter-alfa-trypsininhibitor til terapeutisk anvendelse og det fremstillede koncentrat

Country Status (12)

Country Link
US (1) US5777081A (ja)
EP (1) EP0724600B1 (ja)
JP (1) JP3650937B2 (ja)
AT (1) ATE213252T1 (ja)
AU (1) AU7996294A (ja)
CA (1) CA2174231C (ja)
DE (1) DE69429868T2 (ja)
DK (1) DK0724600T3 (ja)
ES (1) ES2173927T3 (ja)
FR (1) FR2711371B1 (ja)
PT (1) PT724600E (ja)
WO (1) WO1995011260A1 (ja)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3626982B2 (ja) * 1997-08-29 2005-03-09 アークレイ株式会社 タンパク質分解酵素阻害物質の測定方法およびそれに用いる測定キット
US6596705B1 (en) 1998-02-09 2003-07-22 The Regents Of The University Of California Inhibition of L-selectin and P-selection mediated binding using heparin
US6660482B1 (en) 2000-02-28 2003-12-09 Rhode Island Hospital Inter-alpha-trypsin inhibitor as a marker for sepsis
AU2002216968A1 (en) * 2000-10-13 2002-04-22 Octapharma Ag Plasma fraction containing bikunin, method for the production thereof and use of the same
EP1542704A1 (en) * 2002-04-18 2005-06-22 Stephen H. Embury Method and composition for preventing pain in sickle cell patients
USRE47972E1 (en) 2003-11-08 2020-05-05 Prothera Biologics, Inc. Preparation and composition of inter-alpha inhibitor proteins from human plasma for therapeutic use
ES2673005T3 (es) * 2008-05-28 2018-06-19 Prothera Biologics, Inc Preparación y composición de proteínas inter-alfa inhibidoras a partir de sangre
WO2011150284A2 (en) 2010-05-26 2011-12-01 Baxter International Inc. Removal of serine proteases by treatment with finely divided silicon dioxide
AU2010202125B1 (en) 2010-05-26 2010-09-02 Takeda Pharmaceutical Company Limited A method to produce an immunoglobulin preparation with improved yield
MX2013000958A (es) * 2010-07-23 2013-11-20 Baxter Healthcare Sa Fabricación del inhibidor-inter-alfa (iaip) a partir de plasma.
US9572872B2 (en) 2012-09-09 2017-02-21 Prothera Biologics, Inc. Treatment of disease using inter-alpha inhibitor proteins
CN103880951B (zh) * 2014-03-31 2016-03-30 南昌市万华生化制品有限公司 一种通过乌司他丁亲和层析介质制备纯品乌司他丁的方法
EP3362464B1 (en) * 2015-10-15 2021-04-28 Plasma Technologies LLC Methods for extracting proteins from blood plasma
CN109776674B (zh) * 2019-02-19 2020-01-17 广东天普生化医药股份有限公司 纯化的乌司他丁及其制备方法和含有该乌司他丁的药物组合物
TW202142562A (zh) 2020-03-05 2021-11-16 美商迪亞醫藥美國公司 烏司他丁多肽

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1434199A (fr) * 1964-01-10 1966-04-08 Behringwerke Ag Procédé d'isolement d'inhibiteurs de la plasmine et de la trypsine à partir de liquides organiques d'origine humaine ou animale
US4119774A (en) * 1976-03-05 1978-10-10 Ab Kabi Heparin purification method
AT368883B (de) * 1980-07-22 1982-11-25 Immuno Ag Verfahren zur herstellung einer neuen blutgerinnungsfoerdernden praeparation auf basis von humanproteinen
US4760130A (en) * 1984-12-06 1988-07-26 Synergen Biologicals, Inc. Serine protease inhibitors and methods for isolation of same
US4629567A (en) * 1986-03-07 1986-12-16 Smithkline-Rit Alpha-1-antiprotease purification
EP0317376B2 (fr) * 1987-10-23 1996-04-03 Centre Regional De Transfusion Sanguine De Lille Préparation de concentré de facteur IX humain de haute pureté et d'autres protéines plasmatiques
US5445958A (en) * 1987-12-22 1995-08-29 National Blood Authority Process for purifying blood clotting factors

Also Published As

Publication number Publication date
DE69429868T2 (de) 2002-09-19
WO1995011260A1 (fr) 1995-04-27
CA2174231C (fr) 2004-06-01
CA2174231A1 (fr) 1995-04-27
PT724600E (pt) 2002-07-31
ATE213252T1 (de) 2002-02-15
EP0724600A1 (fr) 1996-08-07
JP3650937B2 (ja) 2005-05-25
DE69429868D1 (de) 2002-03-21
JPH09503775A (ja) 1997-04-15
FR2711371B1 (fr) 1995-12-29
US5777081A (en) 1998-07-07
AU7996294A (en) 1995-05-08
EP0724600B1 (fr) 2002-02-13
ES2173927T3 (es) 2002-11-01
FR2711371A1 (fr) 1995-04-28

Similar Documents

Publication Publication Date Title
DK0724600T3 (da) Fremgangsmåde til fremstilling af et koncentrat af inter-alfa-trypsininhibitor til terapeutisk anvendelse og det fremstillede koncentrat
DK0703922T3 (da) Fremgangsmåde til fremstilling af immunoglobulin G koncentrat
CA2210022A1 (en) Paroxetine hydrochloride solvates
DK0397060T3 (da) Maleinimidderivater og deres anvendelse som lægemidler
PT723538E (pt) Compostos triciclicos de carbamato uteis para a ainibicao da funcao da proteina g e para o tratamento de doencas proliferativas
DK0966447T3 (da) Anvendelige små molekyler til behandling af betændelsessygdomme
DK1014966T3 (da) Farmaceutisk præparat til behandling af neurologiske og neuropsykiatriske lidelser
UA27911C2 (uk) Засіб для лікування або запобігання фізіологічних розладів, які викликані надлишком тахікініну
DK0763055T3 (da) Perflouralkylketon-inhibitorer af elastase og fremgangsmåde til fremstilling deraf
DK1571208T3 (da) Fremgangsmåde til ny faktor IX-rensning
UA48940C2 (uk) Рекомбінатні il4 антитіла, які використовуються для лікування il4-опосередкованих порушень
DK0509036T3 (da) Optisk ren R(-)-albuterol til behandling af astma
DK0845943T3 (da) Nye peptider afledt fra humant heat shock protein 60 til behandling af diabetes, sammensætninger, fremgangsmåder og kits
AU633925B2 (en) Process for the preparation of purified albumin solutions
BG102064A (en) Method for increasing the retinal blood circulation
DK0814791T3 (da) Aminotetralin-derivat til behandlingen af cardiovaskulære sygdomme
DK1152760T3 (da) Anvendelse af 4-aminopyridin til behandling af perifere neuropatier
DK0808306T3 (da) Hidtil ukendte pyridin- eller pyridazinderivater, fremgangsmåder til fremstilling deraf og lægemidler indeholdende disse fo
DK0707477T3 (da) Anvendelse af Efaxoran og derivater deraf til fremstilling af lægemidler beregnet til behandling af neurodegenerative sygdo
RU93035807A (ru) Способ лечения юношеского эпифизиолиса
MX9605668A (es) Sal de estilbazolio, su preparacion y uso.